TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
BPOM suspends licences of two more drug firms amid probe into child deaths
Indonesia temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
Change Size
National Food and Drug Monitoring Agency (BPOM) Penny Kusumastuti Lukito leads a raid on herbal drinks and illegal medicine in Cilincing, North Jakarta on Sept. 21, 2018. (Tempo/ M Julnis Firmansyah)
T
he Food and Drug Monitoring Agency (BPOM) said on Wednesday it had suspended the licences of two more local drug companies producing syrup-type medications, as authorities investigate the deaths of nearly 200 children due to acute kidney injury.
Indonesia temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
The two ingredients are used in antifreeze and brake fluids and other industrial applications but also as a cheaper alternative in some pharmaceutical products to glycerine, a solvent or thickening agent in many cough syrups. They can be toxic and lead to acute kidney injury.
Penny K. Lukito, chief of the BPOM, told reporters the companies - PT Samco Farma and PT Ciubros Farma - used high levels of ethylene glycol and diethylene glycol in their products.
The companies had been ordered to pull the products and destroy remaining batches, she said, adding it also temporarily revoked their production licences.
Samco Farma and Ciubros Farma did not immediately respond to requests for comment.
Indonesian authorities were investigating raw material supply chains and screening processes to understand how an excess amount of the ingredients got into products, said Penny.
"The distribution line is long, from importers to some chemical product distributors and big traders until the raw ingredients reach the pharmaceutical industries," she said.
Earlier this week, BPOM suspended the distribution licences of three other companies making products that it said contained a high-level of ethylene glycol and diethylene glycol.
Indonesia has been investigating the deaths in consultation with the World Health Organization (WHO) after a similar incident in Gambia this year, which has seen at least 70 deaths related to syrup medications made by India's Maiden Pharmaceuticals.
